WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012112345) MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/112345    International Application No.:    PCT/US2012/024210
Publication Date: 23.08.2012 International Filing Date: 08.02.2012
IPC:
C07D 471/18 (2006.01), C07D 513/18 (2006.01), C07D 471/22 (2006.01), C07D 498/22 (2006.01), C07D 515/18 (2006.01), A61K 31/439 (2006.01), A61K 31/4995 (2006.01), A61P 31/14 (2006.01)
Applicants: ELANCO ANIMAL HEALTH IRELAND LIMITED [US/US]; C/o Eli Lilly And Company Lilly Corporate Center Indianapolis, Indiana 46285 (US) (For All Designated States Except US).
THURING, Johannes, Wilhelmus J. [NL/BE]; (US) (For US Only)
Inventors: THURING, Johannes, Wilhelmus J.; (US)
Agent: SALES, James J.; C/O ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 (US)
Priority Data:
11154265.0 14.02.2011 EP
Title (EN) MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS
(FR) INHIBITEURS D'INTÉGRASE MACROCYCLIQUES POUR UTILISATION DANS LE TRAITEMENT DU VIRUS DE L'IMMUNODÉFICIENCE FÉLINE
Abstract: front page image
(EN)This invention concerns to naphthyridin derivatives of formula (I) for use in the treatment or prevention of feline immunodeficiency virus (FIV). Furthermore the present invention relates to a method of treating or preventing infection of feline immunodeficiency virus in a feline animal wherein said method comprises the administration to said feline animal of a therapeutically effective amount of a naphthyridin derivative.
(FR)La présente invention concerne des dérivés de naphtyridine de formule (I) pour utilisation dans le traitement prophylactique ou thérapeutique du virus de l'immunodéficience féline (VIF). En outre, la présente invention concerne une méthode de traitement prophylactique ou thérapeutique de l'infection d'un animal félin par le virus de l'immunodéficience féline, ladite méthode comprenant l'administration audit animal félin d'une quantité thérapeutiquement active d'un dérivé de naphtyridine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)